Fredric N. Eshelman is Chairman at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI). They have made 45 open-market trades across 6 companies since 2006, most recently 2022-04-01.
CIK 0001033409
30 open-market purchases totalling $94.1M since 2011, against 15 sales. Across 7 scored buys the stock is up 24.0% at ninety days, and 17.3 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 86% | 86% |
| Avg Move | +9.7% | +4.3% | +24.0% |
| Alpha | +6.3% | +0.5% | +17.3% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 63% | 25% | 100% |
| Avg Move | -0.1% | +6.8% | -5.5% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LQDA | SELL | 2021-01-26 | 2021-01-27 | $3.12 | $11.0M | +21.8% | -1.7% | -0.7% |
| LQDA | SELL | 2021-01-21 | 2021-01-22 | $2.96 | $972K | -2.6% | +13.9% | -8.3% |
| LQDA | SELL | 2021-01-19 | 2021-01-21 | $2.96 | $872K | -5.6% | +12.8% | -5.2% |
| LQDA | SELL | 2021-01-15 | 2021-01-19 | $3.01 | $81K | -8.4% | +10.0% | -9.4% |
| LQDA | SELL | 2021-01-13 | 2021-01-15 | $3.02 | $219K | -4.4% | +20.8% | -8.1% |
| LQDA | SELL | 2020-12-18 | 2020-12-22 | $3.14 | $660K | -3.9% | -1.6% | -10.9% |
| LQDA | SELL | 2020-11-27 | 2020-12-01 | $3.13 | $1K | +1.0% | +0.0% | -0.7% |
| LQDA | SELL | 2020-11-19 | 2020-12-01 | $3.16 | $2.8M | +1.0% | +0.0% | -0.7% |
| LQDA | BUY | 2020-03-30 | 2020-04-01 | $4.83 | $213K | +27.9% | +5.3% | +72.9% |
| EYEN | BUY | 2018-01-29 | 2018-02-06 | $10.00 | $3.4M | +5.8% | +8.0% | +2.2% |
| MDCO | BUY | 2017-12-07 | 2017-12-11 | $26.56 | $5.3M | +4.6% | -0.4% | +33.5% |
| GTHX | BUY | 2017-11-13 | 2017-11-15 | $19.73 | $4.9M | +7.2% | +0.9% | -0.5% |
| GTHX | BUY | 2017-05-22 | 2017-05-24 | $15.00 | $4.5M | +8.4% | +5.4% | +2.3% |
| MDCO | BUY | 2016-12-06 | 2016-12-08 | $33.62 | $30.5M | +5.0% | +4.0% | +49.2% |
| MDCO | BUY | 2016-05-12 | 2016-05-13 | $33.68 | $10.1M | +8.8% | +7.1% | +8.1% |
| FURX | BUY | 2012-06-13 | 2012-06-15 | $18.64 | $1.5M | N/A | N/A | N/A |
| FURX | BUY | 2012-05-31 | 2012-06-04 | $19.92 | $2.4M | N/A | N/A | N/A |
| FURX | BUY | 2012-05-29 | 2012-05-31 | $19.91 | $3.4M | N/A | N/A | N/A |
| FURX | BUY | 2012-05-25 | 2012-05-29 | $18.45 | $27K | N/A | N/A | N/A |
| FURX | BUY | 2012-05-24 | 2012-05-25 | $17.99 | $486K | N/A | N/A | N/A |
| FURX | BUY | 2012-05-22 | 2012-05-24 | $17.22 | $947K | N/A | N/A | N/A |
| FURX | BUY | 2012-05-21 | 2012-05-22 | $16.15 | $39K | N/A | N/A | N/A |
| FURX | BUY | 2012-05-18 | 2012-05-21 | $15.28 | $382K | N/A | N/A | N/A |
| FURX | BUY | 2012-03-15 | 2012-03-19 | $23.91 | $170K | N/A | N/A | N/A |
| FURX | BUY | 2012-03-13 | 2012-03-15 | $23.60 | $1.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| PPDI |
| 6,984,741 |
| — |
| Total | $209.0M |
Shares reported on the most recent Form 4, priced at the 2022-04-04 close. 2 holdings could not be priced and are excluded from the total.
| Scored | 8 | 8 | 8 |